diphenoxylate hydrochloride and atropine sulfate
Generic: diphenoxylate hydrochloride and atropine sulfate
Labeler: direct rxDrug Facts
Product Profile
Brand Name
diphenoxylate hydrochloride and atropine sulfate
Generic Name
diphenoxylate hydrochloride and atropine sulfate
Labeler
direct rx
Dosage Form
TABLET
Routes
Active Ingredients
atropine sulfate .025 mg/1, diphenoxylate hydrochloride 2.5 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
72189-336
Product ID
72189-336_2c3d9a97-2f79-1c66-e063-6294a90ab5c4
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA213413
DEA Schedule
cv
Listing Expiration
2026-12-31
Marketing Start
2022-03-07
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
72189336
Hyphenated Format
72189-336
Supplemental Identifiers
RxCUI
UNII
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
diphenoxylate hydrochloride and atropine sulfate (source: ndc)
Generic Name
diphenoxylate hydrochloride and atropine sulfate (source: ndc)
Application Number
ANDA213413 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- .025 mg/1
- 2.5 mg/1
Packaging
- 10 TABLET in 1 BOTTLE (72189-336-10)
- 30 TABLET in 1 BOTTLE (72189-336-30)
Packages (2)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "2c3d9a97-2f79-1c66-e063-6294a90ab5c4", "openfda": {"unii": ["03J5ZE7KA5", "W24OD7YW48"], "rxcui": ["1190572"], "spl_set_id": ["d9a36478-4788-4107-e053-2a95a90ad6da"], "manufacturer_name": ["Direct Rx"]}, "finished": true, "packaging": [{"sample": false, "description": "10 TABLET in 1 BOTTLE (72189-336-10)", "package_ndc": "72189-336-10", "marketing_start_date": "20220307"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (72189-336-30)", "package_ndc": "72189-336-30", "marketing_start_date": "20220307"}], "brand_name": "DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE", "product_id": "72189-336_2c3d9a97-2f79-1c66-e063-6294a90ab5c4", "dosage_form": "TABLET", "pharm_class": ["Anticholinergic [EPC]", "Antidiarrheal [EPC]", "Cholinergic Antagonists [MoA]", "Cholinergic Muscarinic Antagonist [EPC]", "Cholinergic Muscarinic Antagonists [MoA]"], "product_ndc": "72189-336", "dea_schedule": "CV", "generic_name": "DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE", "labeler_name": "Direct Rx", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE", "active_ingredients": [{"name": "ATROPINE SULFATE", "strength": ".025 mg/1"}, {"name": "DIPHENOXYLATE HYDROCHLORIDE", "strength": "2.5 mg/1"}], "application_number": "ANDA213413", "marketing_category": "ANDA", "marketing_start_date": "20220307", "listing_expiration_date": "20261231"}